The Joint Commission recently published new patient care standards that are embedded within the accreditation manual. Listed under the Provision of Care, Treatment and Services (PC) chapter, these new standards require all accredited hospitals with the obstetric service line to provide evidence of compliance with the new elements of performance. The patient care standards aim to address obstetric hemorrhage and hypertension/pre-eclampsia through prevention, identification and treatment. To prove compliance, beginning in July 2020, hospitals are required to implement several strategies to address well-known management shortcomings in the two major complications. This webinar will discuss the requirements, rationale and references for each element of performance designed to improve quality of care and patient safety during the perinatal period. PeriGen supports The Joint Commission’s aim to improve care of maternal and fetal patients through prompt recognition and early treatment through a variety of modalities including policy and procedures, staffing and patient education.
Included in this discussion will be the introduction of PeriGen’s automated early warning system, PeriWatch Vigilance®. Powered by artificial intelligence, PeriWatch Vigilance® addresses early identification of a patient’s worsening condition through visual display and analyses of maternal vital signs, fetal heart rate and uterine contraction patters, as well as labor progress. It notifies the caregiver when any of these measures exceed safety limits set by the institution. It can provide an objective and tireless assessment throughout labor. If the mother were to experience acute blood loss or severe hypertension, PeriWatch Vigilance® will recognize the aberrant vital signs, identify fetal intolerance and notify the clinicians.
According to their website, The Joint Commission has decided to delay implementation of the new perinatal safety standards until January 1, 2021. The delayed implementation will allow hospitals to continue to focus their attentions on the COVID-19 outbreak. To learn more, you can visit their site.